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docrine cell hyperplasia can present in various 
forms.(3) When the proliferation is restricted to 
the bronchial and bronchiolar epithelium, it is 
known as diffuse idiopathic pulmonary neuroen-
docrine cell hyperplasia; when the proliferation 
extends beyond the basal membrane, the foci 
are designated tumorlets, which, in turn, can be 
localized or diffuse; and, finally, when the proli-
feration forms nodules greater than 5 mm, it is 
known as a carcinoid tumor.
The first case series of diffuse idiopathic 
pulmonary neuroendocrine cell hyperplasia, 
involving 6 patients, was conducted by Aguayo 
Introduction
Pulmonary neuroendocrine cells are widely 
distributed within the airway mucosa and play a 
multifunctional role in pulmonary homeostasis 
because they produce serotonin and a variety 
of neuropeptides, such as bombesin.(1) Recent 
studies suggest that, during lung development, 
these cells play an important role in sensitivity 
to oxygen and in the regeneration of the distal 
lung epithelium.(2)
Focal (localized) neuroendocrine cell hyper-
plasia can be accompanied by various lung 
diseases, such as COPD, lung abscess, cystic 
fibrosis and bronchiectasis. Pulmonary neuroen-
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Abstract
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia with airflow obstruction is a rare form of lung injury. 
All of the reported cases have been diagnosed by surgical lung biopsy. Only three of the reported cases presented 
with diffuse interstitial lung opacities on HRCT scans. We report three additional cases of this entity. All of the 
patients were female and presented with mild-to-moderate airflow obstruction. In the first case, transbronchial 
biopsy and imaging data were sufficient to make the diagnosis. Although the HRCT scans of all three cases revealed 
a mosaic pattern, that of the third patient also revealed diffuse interstitial infiltrate. In extremely rare cases, HRCT 
findings can simulate those seen in other interstitial lung diseases.
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Resumo
A hiperplasia de células neuroendócrinas pulmonares difusas com obstrução ao fluxo aéreo é uma lesão pulmonar 
rara. Todos os casos publicados foram diagnosticados por biópsia pulmonar cirúrgica. Apenas três casos relatados 
apresentavam opacidades intersticiais difusas na TCAR. Nós relatamos três casos adicionais desta entidade. Todos 
eram mulheres, com obstrução leve ou moderada ao fluxo aéreo. No primeiro caso, uma biópsia transbrônquica, 
associada com dados de imagem foram considerados suficientes para o diagnóstico. Um padrão em mosaico foi 
observado nos três casos, mas no terceiro um infiltrado pulmonar difuso foi também observado. Em casos muito 
raros, o aspecto na TCAR pode simular aquele encontrado em outras doenças pulmonares intersticiais. 
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ratio, 64%; total lung capacity (TLC), 4.29 L 
(89%); residual volume (RV), 2.29 L (175%); 
and specific airway conductance, corrected for 
pulmonary resistance, 0.076 L/s/cmH2O/L. After 
the use of albuterol (400 μg), lung volumes and 
FEV1 were unaltered. However, specific airway 
conductance increased to 0.116 L/s/cmH2O/L. 
The predicted values were those suggested for 
the Brazilian population.(11) The functional diag-
nosis was moderate obstructive lung disease 
accompanied by air trapping.
Bronchoscopy with transbronchial biopsy 
was performed (Figure 1c).
The histological findings revealed prolife-
ration of small cells, without atypia, located in 
the airway walls and forming nodular aggre-
gates that tested positive for epithelial markers 
(carcinoembryonic antigen and CK7) and 
neuroendocrine markers (chromogranin and 
synaptophysin), as determined by immunohis-
tochemistry (Figure 1d). There was concomitant 
fibrosis, accompanied by focal obliteration of the 
bronchiolar lumen, as well as mild chronic inflam-
matory infiltrate and focal bronchiolectasis.
The correlation among clinical, tomogra-
phic and histopathological findings allowed 
the diagnosis of tumorlets accompanied by 
diffuse idiopathic pulmonary neuroendocrine 
cell hyperplasia. If the diffuse idiopathic pulmo-
et al. in 1992.(4) The largest case series, involving 
19 patients, was published in 2007.(5) One case 
report has been published in Brazil.(6)
Some authors use the term neuroendocrine 
cell bronchiolitis to refer to diffuse idiopathic 
pulmonary neuroendocrine cell hyperplasia 
accompanied by functional evidence of airway 
obstruction, a syndrome that overlaps both 
clinically and morphologically with bronchiolitis 
obliterans.(4,7,8)
All of the cases reported to date have been 
diagnosed by open lung biopsy or lobectomy. 
Chest CT findings of areas of mosaic perfu-
sion are common,(8,9) suggesting a diagnosis of 
bronchiolitis.
In the present study, we report three cases, 
the first of which was diagnosed by transbron-
chial biopsy and the second and third of which 
were diagnosed by surgical lung biopsy. The third 
patient presented with tomographic findings 
of diffuse interstitial disease, which has been 
observed in only three reported cases.(9,10) All of 
the patients presented with airflow limitation.
Case report
Case 1
A 49-year-old nonsmoking female, who 
worked as a teacher, presented with a six-month 
history of dry cough and mild dyspnea. A routine 
exercise stress test to monitor arterial hyperten-
sion revealed that the patient “got too tired”. 
She was then submitted to chest X-ray and 
referred to the Department of Pulmonology of 
the São Paulo Hospital for State Civil Servants. 
The patient reported household exposure to 
birds for three years.
Physical examination revealed that the patient 
was in good general health and had no apparent 
respiratory distress, as well as presenting a heart 
rate of 68 bpm, a respiratory rate of 16 breaths/
min and normal vesicular sounds. The rest of the 
physical examination was normal.
A chest X-ray and an HRCT scan (Figures 1a 
and 1b, respectively) revealed small nodules of 
varying sizes accompanied by lobulated areas of 
air trapping.
A pulmonary function test performed at 
admission, with lung volumes measured by 
plethysmography, revealed the following: FVC, 





Figure 1 - In a), chest X-ray revealing bilateral small 
nodules. In b), HRCT scan of the chest revealing 
bilateral small nodules. In c), transbronchial biopsy 
sample revealing proliferation of small cells, without 
atypia, in nodular aggregates, as well as fibrosis 
accompanied by focal obliteration of the bronchiolar 
lumen (H&E; ×100). In d), immunohistochemical 
positivity for chromogranin in the cells of interest.
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(172%). There was no significant variation after 
bronchodilator use.
The HRCT scan of the chest revealed bila-
teral small pulmonary nodules, and surgical lung 
biopsy showed nodules consisting of prolifera-
tion of small cells, located in the small airway 
walls, with strong positivity (brown staining) for 
neuroendocrine markers (synaptophysin). The 
histological diagnosis was multiple carcinoid 
tumors (Figure 2).
The patient developed chronic cough and 
progressive dyspnea on exertion, together with 
episodes of bronchospasm. In 2005, another 
pulmonary function test revealed that FEV1 had 
decreased to 0.59 L (44%), again without varia-
tion after bronchodilator use.
During the follow-up period, the patient 
was treated with bronchodilators and inhaled 
corticosteroids.
Case 3
A 64-year-old female presented with a 
ten-year history of dry cough and dyspnea on 
exertion, both of which had worsened over the 
last four months. The patient denied any occu-
pational or environmental exposure of interest.
A pulmonary function test revealed mild 
obstructive lung disease accompanied by a slight 
reduction in DLCO and without hypoxemia.
An HRCT scan of the chest revealed diffuse 
interstitial disease with a reticular septal pattern, 
subpleural areas of ground-glass attenuation 
and areas of air trapping at the lung bases 
(Figures 3a and 3b).
Surgical lung biopsy revealed bronchiolitis 
obliterans accompanied by neuroendocrine cell 
hyperplasia. Immunohistochemistry for chromo-
granin showed proliferation of neuroendocrine 
cells under the respiratory epithelium (Figures 3c 
and 3d).
The patient was treated with prednisone and 
an inhaled corticosteroid, having remained clini-
cally and functionally stable for two years after 
the initial evaluation.
Discussion
Diffuse idiopathic pulmonary neuroendo-
crine cell hyperplasia is a rare disease. To date, 
there have been sixty-six reported cases, most 
of which were included in one of three case 
series.(4,5,12)
nary neuroendocrine cell hyperplasia were only 
focal, there would be no airflow obstruction 
and, consequently, there would not be exten-
sive air trapping on the HRCT scan. The presence 
of carcinoid tumors is characterized by a chest 
HRCT finding of multiple nodules greater than 
5 mm in diameter.
The patient was treated with prednisone 
(40 mg/day) for three months, and there were 
no significant functional changes.
Case 2
A 76-year-old nonsmoking female presented 
with a 15-day history of dry cough, dyspnea and 
fever. The patient had been treated as having 
bronchial infection and bronchospasm and had 
presented improvement. She reported weight loss 
(10 kg) in the last three years. In addition, the 
patient reported symptoms of gastroesophageal 
reflux and denied any occupational exposure of 
interest.
Physical examination revealed that the patient 
had lost weight and presented an overall reduc-
tion in breath sounds, with prolonged expiratory 
time. An HRCT scan of the chest revealed hype-
rinflation and multiple pulmonary nodules.
A pulmonary function test performed in 
1999 revealed the following: FVC, 1.54 L (59%); 
FEV1, 0.90 L (49%); FEV1/FVC ratio, 58%; TLC 




Figure 2 - In a) and b), HRCT scan of the chest 
revealing small nodules with a sparse bilateral 
distribution. In c), proliferation of small cells in 
the walls of the terminal bronchioles (H&E; ×40). 
In d), peribronchiolar cell proliferation presenting 
immunohistochemical positivity for synaptophysin 
(×40).
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which explains the denomination bronchiolitis 
obliterans accompanied by neuroendocrine cell 
hyperplasia.(4,5,7,8) Some authors have postulated 
that neuroendocrine cell hyperplasia precedes 
and causes airway fibrosis. Neuroendocrine cells 
can be observed amid airway fibrosis.(8)
The combination of diffuse idiopathic 
pulmonary cell hyperplasia and constrictive 
bronchiolitis is related to the production of 
neuropeptides, such as bombesin, accompanied 
by chronic inflammation.(15)
The combination of bronchiolitis and carci-
noid tumors is observed with variable frequency. 
One group of authors evaluated 25 consecutive 
patients with peripheral carcinoid tumors and 
found that 19 had neuroendocrine cell hyper-
plasia in addition to the dominant carcinoid 
tumor.(12) Of the 25 patients, 8 (32%) had bron-
chiolitis obliterans lesions accompanied by foci 
of neuroendocrine cell hyperplasia, and 2 of 
those 8 patients had airflow obstruction that 
could not be related to smoking or to any other 
condition.(10) Another group of authors,(16) in a 
case series involving 28 patients with multiple 
carcinoid tumors and tumorlets, found that 
only 4 had airflow obstruction and that only 
1 of those 4 had a profile indicative of diffuse 
bronchiolitis.
Pathological evaluation of lung tissue 
obtained by surgical biopsy is the gold standard 
for the diagnosis of diffuse idiopathic pulmonary 
neuroendocrine cell hyperplasia, and, to date, 
all of the reported cases have been diagnosed 
by open lung biopsy or based on the results 
of lobectomy for pulmonary nodules. The first 
case reported here was diagnosed by transbron-
chial biopsy, after the findings were correlated 
with the functional profile and the tomography 
profile. The combination of well-defined nodules 
and areas of air trapping seen on the HRCT 
scan of the chest led the attending physician to 
suspect the diagnosis, since this combination is 
suggestive of carcinoid tumors accompanied by 
bronchiolitis. The finding of neuroendocrine cell 
proliferation in the transbronchial biopsy was 
considered sufficient to make the diagnosis.
Chest CT findings of nodules and areas 
of mosaic perfusion are common,(5,9,12) and 
this can raise the suspicion of hypersensitivity 
pneumonia.
In some cases, only air trapping is reve-
aled, suggesting constrictive bronchiolitis. The 
In the present study, 2 of the patients were 
elderly and all were female—findings that are in 
accordance with those of the three largest publi-
shed case series.(4,5,12) There is no explanation for 
the predominance of females.
Of the three cases reported here, two were 
in nonsmokers and one was in a former smoker. 
Smoking is believed to be unrelated to this 
condition. In a case series involving 19 patients, 
12 had never smoked.(5) In another case series, 
all of the patients were nonsmokers.(4)
Cough and dyspnea are the most common 
findings.(4,5,12) These symptoms were observed in 
all three of the cases presented here. In one case 
series,(5) half of the patients were asymptomatic, 
and the diagnosis was made based on findings of 
pulmonary nodules in patients with neoplasms 
of various types, submitted to a follow-up HRCT 
scan of the chest.
In spirometry tests, obstructive defects are 
common,(4,5) and this can lead to confusion with 
asthma or COPD. Cases of the pseudorestric-
tive pattern in the spirometry test, similarly to 
that described in bronchiolitis obliterans, can 
be observed.(13) Although the disease typically 
remains stable,(5) in some cases, as in one of 
our cases, the obstruction can be progressive.(14) 
Airflow obstruction results from diffuse idiopa-
thic pulmonary neuroendocrine cell hyperplasia, 
as well as from concomitant bronchiolar fibrosis, 
Figure 3 - In a), HRCT scan of the chest revealing 
interlobular septal thickening. In b), HRCT scan of 
the chest revealing interlobular septal thickening, 
subpleural reticular infiltrate and areas of ground-glass 
attenuation. In c), peribronchiolar cell proliferation 
(H&E; ×100). In d), immunohistochemical positivity 
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extent of air trapping on HRCT scans is inver-
sely correlated with FEV1.
(9) Rarely are HRCT 
findings normal.(5) Ground-glass opacities on 
HRCT scans have been described in only three 
reported cases,(9,10) the same occurring in one of 
the cases in the present study. Biopsy revealed 
that fibrosis extended focally, accompanied by 
cell proliferation into the adjacent interstitium, 
which can explain the tomographic findings of 
interstitial disease.
Diffuse idiopathic pulmonary neuroendo-
crine cell hyperplasia is typically indolent and 
is rarely progressive. In one case series,(5) 83% 
of the 19 patients studied were alive five years 
after diagnosis. However, in one case, the patient 
underwent lung transplantation due to progres-
sive disease.
There is little information regarding treat-
ment. In one case series,(4) 2 of the 6 patients 
studied underwent chemotherapy, which resulted 
in no improvement. In one of those two cases, 
the disease had a rapidly progressive evolution, 
resulting in death due to respiratory failure. It is 
recommended that patients be monitored prior 
to treatment. If pulmonary function worsens, 
corticosteroid use should be attempted. There 
are rare reported cases of a clinical and func-
tional response to corticosteroids.(10)
In summary, the present study shows that, 
although rare, diffuse idiopathic pulmonary 
neuroendocrine cell hyperplasia should be 
suspected in cases of airflow obstruction accom-
panied by multiple pulmonary nodules and areas 
of air trapping on HRCT scans. Even more rarely, 
the pattern can be that of diffuse interstitial 
disease.
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